Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Androgen replacement therapy or low testosterone therapy is commonly called as hormone replacement therapy for men. It is designed to counteract the effects of reduced activity in the gonads or hypogonadism. Hypogonadism in men is a clinical syndrome, which results in the failure of the testes to produce physiological levels of testosterone. The primary reason for hypogonadism may be a problem with the testes. The secondary reason is a problem with the hypothalamus or pituitary gland or both primary and secondary. Primary hypogonadism is caused due to genetic abnormalities, testicular trauma, orchitis, radiation treatment or chemotherapy, while secondary hypogonadism is caused due to genetic abnormalities of pituitary gland and hypothalamus. Testosterone injections, implants, gels, creams, and oral medications are used for treatment of hypogonadism.

Global Androgen Replacement Therapy Market - Impact of the Coronavirus (COVID-19) Pandemic

Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 as pandemic on March 11, 2020.

According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 148,329,348 cases and 3,128,962 deaths due to Coronavirus disease (COVID-19) were reported on April 28, 2021, across the globe.

General guidance on medicines management for endocrinology conditions during COVID-19 is available at Society for Endocrinology. This list of guidelines are issued by the National Health Service (NHS), England.

The objective is to advise on the administration and monitoring of testosterone injections during COVID-19 for androgen deficiency in adults, to protect patients from unnecessary health care visits, to help preserve NHS capacity, and to provide options for the management of patients who are self-isolating or have symptoms of COVID-19.

The most commonly prescribed testosterone injections for androgen deficiency in the U.K. include either a long acting intramuscular depot testosterone, Nebido, or short-acting mixed testosterone esters, and Sustanon.

Administration: During the COVID-19 pandemic, options to manage administration include:

1) Temporarily interrupt administration – For most testosterone formulations and most patients, a temporary interruption in the testosterone replacement therapy (TRT) is unlikely to cause harm. It is unlikely that bone or muscle mass will be affected by a 3-4 month interruption of treatment.

2) Switching to testosterone based gel – Empirical dose (Tostran 50 mg daily; Testogel Pump 40.5 mg daily; or Testovance 46 mg daily). The testosterone gel should be commenced from the date the next injection would have been due. The intramuscular preparation could be recommenced, once non-urgent services resume.

The global androgen replacement therapy market is estimated to be valued at US$ 1,965.5 Mn in 2021 and is expected to exhibit a CAGR of 7.8% over the forecast period (2021-2028).

request-sample

Androgen Replacement Therapy Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 1,965.5 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 7.8% 2027 Value Projection: US$ 3,317.6 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Testosterone Creams/Gels, Testosterone Patches, Testosterone Injections, Testosterone Implants, Testosterone Tablets/Capsules/Gums
  • By Active Ingredient Type: Testosterone, Methyl Testosterone, Testosterone Undecanoate, Testosterone Enanthate, Testosterone Cypionate
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Companies covered:

AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Plc., Eli Lilly and Company, Kyowa Kirin International Plc., Novartis International AG, Pfizer Inc., Clarus Therapeutics, Inc., Perrigo Company Plc, Acerus Pharmaceuticals Corporation, Sawai pharmaceutical Co., Ltd., Reddy's Laboratories, Sun Pharmaceutical Industries Ltd., and Simple Pharma.

Growth Drivers:
  • Robust pipeline drugs for treatment of hypogonadism
  • Increasing product approvals and launches
  • Increasing prevalence of hypogonadism
Restraints & Challenges:
  • Stringent regulations and drug recalls
  • Side effects and lack of awareness regarding androgen replacement treatment

Figure 1: Global Androgen Replacement Therapy Market Share (%) Analysis, By Distribution Channel, 2021

Androgen Replacement Therapy  | Coherent Market Insights

The increasing prevalence of hypogonadism and product launches are the major factors that are expected to drive the market growth over the forecast period.

The growing prevalence of hypogonadism in adult men worldwide is expected to drive growth of androgen replacement therapy market over the forecast period. For instance, according to the European Association of Urology: 2016 report, among middle-aged men, incidence of hypogonadism varies from 2.1% to 12.8%. In Europe, the incidence of low testosterone and symptoms of hypogonadism in men in the age group of 40 to 79 varies from 2.1% to 5.7%. Hypogonadism is more prevalent in elderly men, men with obesity, those with co-morbidities, and men with a poor health status.

Moreover, products launches by market players are expected to fuel the androgen replacement therapy market growth in the near future. For instance, in April 2019, Israel-based generics company, Teva Pharmaceutical Industries (Teva), launched generic versions of AndroGel (testosterone gel) 1.62% CIII and VESIcare (solifenacin succinate) tablets of 5 mg and 10 mg, in the U.S. Testosterone gel 1.62% CIII is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone, which include congenital or acquired primary hypogonadism and congenital or acquired hypogonadotropic hypogonadism.

Global Androgen Replacement Therapy Market – Restraints

However, growth of the androgen replacement therapy market may be hampered, owing to the increasing product recalls of testosterone products in the market. For instance, in August 2018, the U.S. subsidiary of Sun Pharmaceutical Industries Ltd. recalled over 5,215 units of 10 ml vials of testosterone cypionate injections, in the strength of 200 mg/ml from the U.S. market, the latest enforcement report of recall was instructed by the U.S. Food and Drug Administration (U.S. FDA). According to the U.S. FDA report, the ongoing voluntary nationwide recall is a Class II recall, initiated in a situation. The testosterone cypionate injections was recalled due to the possibility of it causing temporary or medically reversible adverse health consequences.

Global Androgen Replacement Therapy Market – Regional Analysis

On the basis of region, the global androgen replacement therapy market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America region is expected to hold dominant position in the global androgen replacement therapy market over the forecast period, owing to increasing number of product launches and approvals associated with androgen replacement therapy by regulatory bodies. For instance, in February 2019, Innovus Pharmaceuticals, Inc., a commercial-stage pharmaceutical company, received approval from the Health Canada for BH Testosterone Booster capsules, indicated to maintain the testosterone levels and production in adult males.

Furthermore, Asia Pacific is also estimated to witness significant growth in the androgen replacement therapy market, owing to increasing number of agreements by market players, over the forecast period. For instance, in August, 2020, Antares Pharma, Inc., a pharmaceutical technology company, entered into an exclusive distribution agreement with Lunatus Global Medical Supplies (‘Lunatus’) for the distribution and promotion of XYOSTED, a testosterone enanthate injection, in Saudi Arabia and the United Arab Emirates (UAE).

Figure 2: Global Androgen Replacement Therapy Market Value (US$ Mn), by Region, 2020

Androgen Replacement Therapy  | Coherent Market Insights

Global Androgen Replacement Therapy Market – Competitive Landscape

Major players operating in the global androgen replacement therapy market include AbbVie, Inc., Bayer AG, Endo International plc, Eli Lilly and Company, Kyowa Kirin International Plc., Novartis International AG, Pfizer Inc., Clarus Therapeutics, Inc., Perrigo Company Plc, Acerus Pharmaceuticals Corporation, Sawai pharmaceutical Co., Ltd., Reddy's Laboratories, Sun Pharmaceutical Industries Ltd., and Simple Pharma.

Androgen replacement therapy (ART), often referred to as testosterone replacement therapy (TRT), is a form of hormone therapy, in which androgens, often testosterone, are replaced. ART is often prescribed to counter the effects of male hypogonadism. It typically involves the administration of testosterone through injections, skin creams, patches, gels, or subcutaneous pellets. Testosterone replacement therapy is a promising technology for improving symptoms of hypogonadism and to raise the testosterone level. Furthermore, benefits related to application of testosterone replacement therapy include an increase in muscle tissue, overall surge in energy, and significant decrease in depression symptoms.

Market Dynamics

The androgen replacement therapy market is expected to witness growth during the forecast period, owing to the increasing number of product launches in the market. For instance, n November 2018, Antares Pharma, Inc. announced the commercial launch of XYOSTED, a subcutaneous injection of testosterone enanthate. XYOSTED was launched in three dosage strengths, 50 mg, 75 mg and 100 mg and is indicated for testosterone replacement therapy. 

Key players are entering long term collaborations and agreements, which is expected to propel growth of the global androgen replacement therapy market during the forecast period. For instance, in June 2019, AbbVie, Inc. acquired Allergan, a global pharmaceutical company, in a cash and stock transaction for a transaction equity value of around US$ 63 billion, based on the closing price of AbbVie's common stock of US$ 78.45 on June 24, 2019. As a result of this acquisition, Abbivie, Inc. enhanced its long-term R&D funding capacity, allowing for continued investment and expand its product portfolio.

However, the side effects caused due to androgen replacement therapy are expected to hamper the androgen replacement therapy market growth. The side effects from the androgen replacement therapy include chest pain, shortness of breath or trouble breathing, weakness in one part or one side of the body, slurred speech, sleep apnea, increased cholesterol levels, and increased blood pressure. For instance, in 2015, the U.S. FDA issued a warning about potential cardiovascular risks such as heart attack and stroke resulting from testosterone therapy.

Key features of the study:

  • This report provides an in-depth analysis of global androgen replacement therapy market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global androgen replacement therapy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Plc., Eli Lilly and Company, Kyowa Kirin International Plc., Novartis International AG, Pfizer Inc., Clarus Therapeutics, Inc., Perrigo Company Plc, Acerus Pharmaceuticals Corporation, Sawai pharmaceutical Co., Ltd., Reddy's Laboratories, Sun Pharmaceutical Industries Ltd., and Simple Pharma.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global androgen replacement therapy market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the androgen replacement therapy market

Detailed Segmentation:

  • Global Androgen Replacement Therapy Market, By Product Type:
    • Testosterone Creams/Gels
    • Testosterone Patches
    • Testosterone Injections
    • Testosterone Implants
    • Testosterone Tablets/Capsules/Gums
  • Global Androgen Replacement Therapy Market, By Active Ingredient Type:
    • Testosterone
    • Methyl Testosterone
    • Testosterone Undecanoate
    • Testosterone Enanthate
    • Testosterone Cypionate
  • Global Androgen Replacement Therapy Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Androgen Replacement Therapy Market, By Region:
    • North America
      • By Product Type:
        • Testosterone Creams/Gels
        • Testosterone Patches
        • Testosterone Injections
        • Testosterone Implants
        • Testosterone Tablets/Capsules/Gums
      • By Active Ingredient Type:
        • Testosterone
        • Methyl Testosterone
        • Testosterone Undecanoate
        • Testosterone Enanthate
        • Testosterone Cypionate
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Testosterone Creams/Gels
        • Testosterone Patches
        • Testosterone Injections
        • Testosterone Implants
        • Testosterone Tablets/Capsules/Gums
      • By Active Ingredient Type:
        • Testosterone
        • Methyl Testosterone
        • Testosterone Undecanoate
        • Testosterone Enanthate
        • Testosterone Cypionate
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Testosterone Creams/Gels
        • Testosterone Patches
        • Testosterone Injections
        • Testosterone Implants
        • Testosterone Tablets/Capsules/Gums
      • By Active Ingredient Type:
        • Testosterone
        • Methyl Testosterone
        • Testosterone Undecanoate
        • Testosterone Enanthate
        • Testosterone Cypionate
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Testosterone Creams/Gels
        • Testosterone Patches
        • Testosterone Injections
        • Testosterone Implants
        • Testosterone Tablets/Capsules/Gums
      • By Active Ingredient Type:
        • Testosterone
        • Methyl Testosterone
        • Testosterone Undecanoate
        • Testosterone Enanthate
        • Testosterone Cypionate
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Testosterone Creams/Gels
        • Testosterone Patches
        • Testosterone Injections
        • Testosterone Implants
        • Testosterone Tablets/Capsules/Gums
      • By Active Ingredient Type:
        • Testosterone
        • Methyl Testosterone
        • Testosterone Undecanoate
        • Testosterone Enanthate
        • Testosterone Cypionate
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Testosterone Creams/Gels
        • Testosterone Patches
        • Testosterone Injections
        • Testosterone Implants
        • Testosterone Tablets/Capsules/Gums
      • By Active Ingredient Type:
        • Testosterone
        • Methyl Testosterone
        • Testosterone Undecanoate
        • Testosterone Enanthate
        • Testosterone Cypionate
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • AbbVie, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Bayer AG
    • Endo Pharmaceuticals, Plc.
    • Eli Lilly and Company
    • Kyowa Kirin International Plc.
    • Novartis International AG
    • Pfizer Inc.
    • Clarus Therapeutics, Inc.
    • Perrigo Company Plc
    • Acerus Pharmaceuticals Corporation
    • Sawai pharmaceutical Co., Ltd.
    • Reddy's Laboratories
    • Sun Pharmaceutical Industries Ltd.
    • Simple Pharma

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Active Ingredient Type
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Merger and Acquisition
    • Product Launches
    • PEST Analysis
    • Regulatory Scenario
      • Schedule III controlled substances
      • S. FDA regulations associated with risks of abuse and dependence of testosterone and other anabolic androgenic steroids (AAS)
      • Exempt chemical preparations
      • Use of anabolic steroids and associated implications
    • Pipeline Analysis
  4.  Global Androgen Replacement Therapy Market - Impact of Coronavirus (Covid-19) Pandemic
    • COVID-19 Epidemiology
    • Overall Impact Assessment
    • Supply Side And Demand Side Analysis
    • Impact of COVID-19 on Androgen Replacement Therapy Patients
    • Government Recommendations
  5. Global Androgen Replacement Therapy Market, By Product Type, 2017-2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Testosterone Creams/Gels
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Testosterone Patches
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Testosterone Injections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Testosterone Implants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Testosterone Tablets/Capsules/Gums
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  6. Global Androgen Replacement Therapy Market, By Active Ingredient Type, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Testosterone
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Methyl Testosterone
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Testosterone Undecanoate
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Testosterone Enanthate
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Testosterone Cypionate
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  7. Global Androgen Replacement Therapy Market, By Distribution Channel, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  8. Global Androgen Replacement Therapy Market, By Region, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018 - 2028
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Active Ingredient Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Active Ingredient Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Active Ingredient Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Active Ingredient Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Active Ingredient Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Active Ingredient Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Company Profiles
      • AbbVie, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Bayer AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Endo Pharmaceuticals, Plc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Eli Lilly and Company
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Kyowa Kirin International Plc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Novartis International AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Pfizer Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Clarus Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Perrigo Company Plc
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Acerus Pharmaceuticals Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Sawai pharmaceutical co., ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Reddy's Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Sun Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Simple Pharma
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 39 market data tables and 22 figures on "Androgen Replacement Therapy Market” - Global Forecast to 2028.

FAQgrowicon

Frequently Asked Questions

The global androgen replacement therapy market is expected to exhibit a CAGR of 7.8% during the forecast period (2021-2028).
The market is estimated to be valued at US$ 1,965.5 Mn in 2021.
AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Plc., Eli Lilly and Company, Kyowa Kirin International Plc., Novartis International AG, Pfizer Inc., Clarus Therapeutics, Inc., Perrigo Company Plc, Acerus Pharmaceuticals Corporation, Sawai pharmaceutical Co., Ltd., Reddy's Laboratories, Sun Pharmaceutical Industries Ltd., and Simple Pharma., are some of the prominent players operating in the market .
The market is expected to be valued at US$ 3,317.6 Mn in 2028.
Testosterone creams/gels are the mostly used products type in the market.
North America is the prominent region in the market.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner